Wednesday, February 28, 2024 5:09:34 PM
========================================
About the pump piece. Anything italicized is a direct quote from the article posted on the Teslas ihub board
As the business world holds its breath
To kick off the article, it starts with the above. This statement implies there are more people interested in the events than is necessarily true. This is done to stimulate an emotional response in the reader.
is on the verge of announcing a significant corporate development, speculated to be a groundbreaking partnership or a strategic merger, causing its stock to soar in anticipation
Per the companies press release, they are adding a "promising corporate development" to their presentation. Nothing that indicates a major development or partnership. Also the promo piece claims the price is soaring in anticipation. The stock has not been soaring but it is up. This is hallmarks of pump and dump buy the rumor sell the news speculation and is meant to trigger FOMO in the reader.
The postponed shareholder call, initially set for January 11, hints at the imminent finalization of this deal, promising to shake the tech and automotive sectors.
It doesnt hint at the finalization of any such deal or shake the tech/automotive sectors. Again, the press release said they are adding a "promising corporate development" is all thats being claimed. This could something pertaining to R&D, but given the hype/pump pieces, i think there is some sort of financial deal to be disclosed and added to the presentation.
Anticipation Builds Around Corporate Development
The decision to delay the shareholder call suggests that <ticker omitted> is in the final stages of securing a deal that could redefine its corporate trajectory.
Again nothing to indicate this.
This development, coupled with the groundbreaking battery technology, has investors and industry observers on the edge of their seats.
Hyperbole meant to trigger FOMO in the reader. This is all part of the conartists ploy.
The nature of the corporate shift remains the subject of speculation, but the strategic postponement of the shareholder meeting indicates that the announcement will likely herald a new era for <ticker omitted> and its stakeholders.
Here the author of the article indicates this is just speculation as to protect themselves from potential liability. Thats then followed by speculation of the meeting to again try and trigger an emotional response and encourage FOMO.
Let me first just say that this pump piece is nowhere grounded in reality nor does it provide any evidence to support its speculation. The only thing that is grounded is the postponed meeting where the company will add a promising new development. However nothing to indicate the included information will be on the level major significant corporate announcement.
========================================
Lets contrast this with the information i post. I speculate, i acknowledge that. The major difference is my speculation is grounded in real evidence which i share so you can verify. I try to get other posters to engage with me so i can better refine my speculation and better understand whats going on, but i cannot get their help.
Now anyone reading my posts that i claim that Zimmer Biomet is a stakeholder in Sintx and has been since it acquired Centerpulse in 2003 could see that as being false statement. However, I make this claim based on the following evidence:
Shared IP in development:
Sintx femoral head tested against Biomet's E1 liner
https://ir.sintx.com/news-events/press-releases/detail/95/amedica-announces-results-of-independent-femoral-head-wear
Si3N4 coating of Biomet's OsseoTI Acetabular shell
https://www.sciencedirect.com/science/article/abs/pii/S1751616119309099
Shared Personnel:
Dr Sonny Bal, MD, JD, MBA, PHD (Chairman, CEO) was a member of Zimmers designer: Designer Surgeon Panel, Zimmer Inc., Warsaw, Indiana, 2002 to present.
http://www.hipandknee.com/wp-content/uploads/sites/13/2014/04/Dr.-Bal-CV.pdf (link no longer valid)
Dr Link, PHD (Chairman 2003-2014) - Dr. Link served as Chairman of the Board and Chief Executive Officer of Centerpulse AG, the largest orthopedics company in Europe, from March 2002 until October 2003, when Centerpulse was acquired by Zimmer Holdings, Inc
Dr Hofmann, MD (Co-founder/former director) - Dr. Hofmann, working with a team of orthopedic surgeons, helped design Zimmer’s new gender knee specifically designed for women
Whats not included is that Dr Hofmann worked for Centerpulse before its acquisition. So Hofmann & Link both came from Centerpulse originally but both connected to Zimmer post acquisition. You can see a continuity that spans the life of Sintx.
https://www.sec.gov/Archives/edgar/data/1269026/000119312507120692/ds1.htm pg 73/74 under management section.
========================================
Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application
examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.
https://www.mdpi.com/2571-6131/4/2/16/htm
========================================
Electromagnetic fields, metal implant corrosion, and dis-ease it causes
https://i.imgur.com/nLg7SXT.jpg
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779
Could it be that there is a strategy to distract people away from looking at the basic data?
Is all this an exercise to create more and more forum verbiage to drown out any serious discussion of evidence?
Recent SINT News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2026 01:02:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 01:00:18 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/19/2026 02:00:04 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/18/2026 01:35:38 PM
- SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms • GlobeNewswire Inc. • 02/18/2026 01:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:45:54 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:44:43 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/11/2026 01:43:48 AM
- SINTX Technologies to Participate in Noble Capital Markets’ Emerging Growth Virtual Equity Conference on February 4–5 • GlobeNewswire Inc. • 01/29/2026 02:00:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/12/2025 05:15:20 AM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 12/09/2025 10:01:07 PM
- Sidoti Events, LLC's Year-End Virtual Investor Conference • ACCESS Newswire • 12/09/2025 05:48:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/09/2025 01:00:05 PM
- SINTX Technologies to Participate in Sidoti & Company Investor Conference • GlobeNewswire Inc. • 12/08/2025 02:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/08/2025 01:00:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2025 01:35:26 PM
- SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants • GlobeNewswire Inc. • 12/01/2025 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2025 01:05:43 PM
- SINTX Reports Pivotal Third Quarter Business Update and Financial Highlights Driven by FDA Clearance, Product and IP Portfolio Expansions and Increased Operational Efficiencies • GlobeNewswire Inc. • 11/13/2025 01:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2025 09:17:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/10/2025 01:00:06 PM
- SINTX Technologies Announces Launch of OsseoSculpt™ an Advanced Biologic for Use with SINAPTIC® Foot & Ankle Osteotomy Wedge System • GlobeNewswire Inc. • 11/03/2025 01:00:00 PM
Advances in Domestic Heavy Rare Earth Minerals Production Essential for North American Defense Stockpiles • ALOY • Mar 18, 2026 9:00 AM
ECGI Advances $10M Mortgage Tokenization Pilot as SEC Interpretation Adds Clarity • ECGI • Mar 18, 2026 8:45 AM
ECGI Advances Mortgage Tokenization Pilot as Institutional Market Rails Continue to Develop • ECGI • Mar 17, 2026 8:30 AM
Record Gold Prices Reshape Economics of New Mine Development • SNWGF • Mar 16, 2026 10:46 AM
Cannabix Technologies Announces Commercial Launch of Marijuana Breath Test (MBT) • BLOZF • Mar 16, 2026 8:37 AM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
